4.8 Article

MicroRNA-101-mediated Akt activation and estrogen-independent growth

期刊

ONCOGENE
卷 30, 期 7, 页码 822-831

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2010.463

关键词

breast cancer; estrogen receptor; miR-101; tamoxifen resistance

资金

  1. Susan G Komen for the Cure [KG100027]
  2. Department of Defense [BC085629]
  3. Abraxis Bioscience

向作者/读者索取更多资源

MicroRNAs are gene regulators that work through a posttranscriptional repression mechanism. Dysregulation of microRNA expression could lead to a variety of disorders, in particular, human cancer, and has also been implicated in antihormone therapy resistance. However, little is known whether microRNAs have a role in estrogen-independent growth, leading to tamoxifen resistance in estrogen receptor (ER)-positive tumors. In this study, we use an in vivo selection system against a microRNA library using the MCF-7 model and demonstrate that miR-101 promotes estrogen-independent growth and causes the upregulation of phosphorylated Akt (pAkt) without impacting the ER level or activity. Importantly, although miR-101 suppresses cell growth in normal estradiol (E2)-containing medium, it promotes cell growth in E2-free medium. Moreover, estrogen deprivation greatly enhances miR-101-mediated Akt activation. Finally, we show that MAGI-2 (membrane-associated guanylate kinase), a scaffold protein required for PTEN (phosphatase and tensin homolog) activity, is a direct target for miR-101; suppression of MAGI-2 by miR-101 reduces PTEN activity, leading to Akt activation. Taken together, these results not only establish a role for miR101 in estrogen-independent signaling but also provide a mechanistic link between miR-101 and Akt activation. Oncogene (2011) 30, 822-831; doi:10.1038/onc.2010.463; published online 18 October 2010

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据